Relx PLC (RLXXF)
RELX PLC is a London-based company listed on OTC Markets as common stock. Through its subsidiaries, the group provides information-based analytics and decision tools for professional and business customers across North America, Europe, and other international markets. Its operations are organized into four segments: Risk; Scientific, Technical & Medical; Legal; and Exhibitions. The Risk segment combines content, technology, and analytics to support client assessment and prediction of risk, and also includes commercial healthcare products. The Scientific, Technical & Medical segment supplies scientific and medical information and data sets, while the Legal segment focuses on legal, regulatory, and business information and analytics. The Exhibitions segment uses digital tools and data to help customers connect in person and online, explore markets, source products, generate leads, and complete transactions. The company was formerly known as Reed Elsevier PLC and adopted the RELX PLC name in July 2015.
Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Analyst Target Rating | Overall Financial Health | Upcoming Dividend Ex-Date | Dividend Payment Date | Upcoming Dividend | Dividend Yield | Next Earnings Date | P/E Ratio | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Payout Ratio | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
OTC-RLXX.F
|
$41.45
|
30.0% Upside
|
Undervalued
|
—
|
—
|
—
|
Good
|
—
|
—
|
0.91
|
2.7%
|
July 23, 2026
|
21.3x
|
18.6x
|
4.6x
|
59.012 B
|
69.062 B
|
14.1%
|
99.2%
|
3.5
|
57.2%
|
136.3%
|
